Deal Watch: Roche Terminates Gene Therapy Alliance, Partners In IBD With Synlogic
Roche gives back choroideremia candidate to 4D Molecular after reviewing Phase I data, partners on synthetic GI therapy with Synlogic. AbbVie opts to acquire TeneoOne under 2019 agreement.
You may also be interested in...
Private California venture will bring additional expertise and novel platforms to acquisitive biotech giant as it looks to expand its interests in bispecific and multispecific antibody technologies.
Stada has expanded its business with another acquisition in the consumer healthcare space, this time striking a deal with Sanofi for 16 brands across 13 European markets.
Belgian value-added medicines specialist Hyloris Pharmaceuticals has renegotiated its licensing agreement with Alter Pharma group, wrapping up all previous agreements. Under the new agreement, Hyloris will forego all past commitments and all further future royalty obligations to Alter for Maxigesic IV.